Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Total Debt
Short-term and long-term borrowings combined.
Sionna Therapeutics, Inc.NASDAQ: SION
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 11.8% from a year ago
Total debt stood at $8.38M at the end of Q1 FY2026, down 11.8% from a year earlier and down 3.5% from the prior quarter.
Context
- Total debt amounted to 2.7% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Total debt increased in 1 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -11.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 8.68M USD
- Year-over-year change
- -11.0%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.68M | -11.0% |
| FY2024 | 2024-12-31 | 9.75M | -6.9% |
| FY2023 | 2023-12-31 | 10.48M | — |
| FY2022 | 2022-12-31 | 0 | — |
Total Debt vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 total debt of $8.38M is the lowest of the 11 companies compared; the peer median is $68.23M.
- Its year-over-year change of -11.8% is the 10th highest of 11, against a peer median of +18.1%.
- Total debt amounts to 2.7% of total assets for SION, versus a peer median of 11.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $662.71M | +3405.7% | -13.4% | 56.3% | |
| Jun 2026 | $297.04M | +1.9% | +103.8% | 80.1% | |
| Mar 2026 | $208.26M | +34.3% | +79.7% | 41.3% | |
| Sep 2026 | $133.82M | -5.9% | +20.3% | 8.9% | |
| Jun 2026 | $75.23M | -3.0% | +35.2% | 14.1% | |
| Mar 2026 | $61.22M | +137.1% | -10.1% | 14.6% | |
| Mar 2026 | $37.33M | -86.1% | -42.4% | 9.5% | |
| Mar 2026 | $21.57M | -4.6% | -4.4% | 2.1% | |
| Sep 2026 | $10.26M | +155.6% | +136.6% | 2.0% | |
| Sep 2026 | $9.87M | +276.6% | -16.6% | 1.4% | |
| Mar 2026 | $8.38M | -11.8% | — | 2.7% | |
| Peer median (excluding SION) | $68.23M | +18.1% | +8.0% | 11.8% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.